Skip to main content
Log in

The phenotype of L-CFU and its correlation with the immunological characteristics of the blast cell population in AML

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

The membrane phenotype of AML clonogenic cells (L-CFU) was analyzed in 19 AML patients using an in vitro culture technique after a complement-mediated lysis assay employing a panel of six monoclonal antibodies (McAb) -HLA-DR, FMC56 (CD9), FMC27 (CD9), CD14, CD15, CD41a-. Our results show that L-CFU has a heterogeneous but immature phenotype lacking on the expression of differentiation antigens (CD14, CD15, CD41a). In addition, we observed that the L-CFU phenotype is different from that of the whole blast cell population. Interestingly, L-CFU showed a higher expression of HLA-DR antigens with respect to their progeny. Upon analyzing whether the L-CFU phenotype was related to both the morphological and immunological features of AML blast cells, it was observed that, while there is no correlation with the FAB classification, there was a partial relationship between the immunological phenotype of AML blast cells and that of L-CFU. Accordingly, the more immature AML cases showed a more differentiated L-CFU phenotype (HLA-DR+, CD9+, FMC27+) when compared with cases with a more mature blast cell phenotype. These results suggest that those AML cases with a relatively immature myeloblastic phenotype may arise from a progenitor cell that has undergone partial differentiation and that is unable to acquire myeloid differentiation antigens, while those AML cases with mature blast cells might emerge from a very early L-CFU that has the capacity to undergo a greater degree of differentiation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sabbath KD, Griffin JD (1985) Clonogenic cells in acute myeloblastic leukaemia. Scand J Haematol 35:251–256

    Google Scholar 

  2. Griffin JD, Löwenberg B (1986) Clonogenic cells in acute myeloblastic leukemia. Blood 6:1185–1195

    Google Scholar 

  3. Griffin JD, Davis R, Nelson DA, Davey FR, Mayer RJ, Schiffer C, McIntyre OR, Bloomfield CD (1986) Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia. Blood 68:1232–1241

    Google Scholar 

  4. San Miguel JF, Gonzalez M, Cañizo MC, Anta JP, Zola H, Lopez Borrasca A (1986) Surface marker analysis in acute myeloid leukaemia and correlation with FAB classification. Br J Haematol 64:547–560

    Google Scholar 

  5. Ball ED (1990) Immunophenotyping of acute myeloid leukemia cells. Clin Lab Med 10:721–736

    Google Scholar 

  6. Drexler HG, Minowada J (1986) The use of monoclonal antibodies for the identification and classification of acute myeloid leukemias. Leuk Res 10:279–290

    Google Scholar 

  7. Robak T, Dowding C, Garewal G, Hibbin JA, Th'ng KH, Goldman JM (1986) Antigenic determinants on myeloid leukaemia colony-forming cells resemble those of normal myeloid progenitor cells and differ from those of circulating blast cells. Br J Haematol 64:133–148

    Google Scholar 

  8. Kabral A, Bradstock K, Grimsley P, Favaloro EJ (1988) Immunophenotype of clonogenic cells in myeloid leukemia. Leuk Res 12:51–59

    Google Scholar 

  9. Lange B, Ferrero D, Pessano S, Palumbo A, Faust J, Meo P, Rovera G (1984) Surface phenotype of clonogenic cells in acute myeloid leukemia defined by monoclonal antibodies. Blood 64:693–700

    Google Scholar 

  10. Sabbath KD, Ball ED, Larcom P, Davis RB, Griffin JD (1985) Heterogeneity of clonogenic cells in acute myeloblastic leukemia. J Clin Invest 75:746–753

    Google Scholar 

  11. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick H, Sultan C (1976) Proposals for the classification of the acute leukaemias. Br J Haematol 33:451–458

    Google Scholar 

  12. Bennett JM, Catovsky D, Daniel MT, Flandrin D, Galton DAG, Gralnick H, Sultan C (1985) Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 103:626–629

    Google Scholar 

  13. Minden MD, Buick RN, McCulloch EA (1979) Separation of blast cells and T-lymphocyte progenitors in the blood of patients with acute myeloblastic leukemia. Blood 54:186–195

    Google Scholar 

  14. Buick RN, Till JE, McCulloch EA (1977) Colony assay for proliferative blast cells circulating in myeloblastic leukemia. Lancet 1:862–863

    Google Scholar 

  15. Schlossman S, Chess L, Humphreys R, Strominger JL (1976) Distribution of la-like molecules on the surface of normal and leukemic human cells. Proc Natl Acad Sci USA 73:1288–1292

    Google Scholar 

  16. Griffin JD, Ritz Y, Nadler LM, Schlossman SF (1981) Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest 68:932–941

    Google Scholar 

  17. Zola H, McNamara PJ, Beckman IGER, Brooks DA, Macardle PJ, Bradley J, Goodall K, Skinner J, Colins R, Berndt MC (1984) Monoclonal antibodies against antigens of the human platelet surface: preparation and properties. Pathology 16:73–78

    Google Scholar 

  18. Zola H, Potter A, Neoh SH, Juttner CA, Haylock DN, Rice AM, Favaloro EJ, Kabral A, Bradstock KF (1987) Evaluation of a monoclonal IgM antibody for purging of bone marrow for autologous transplantation. Bone Marrow Transplant 1:297–301

    Google Scholar 

  19. Todd RF, Nadler LM, Schlossman SI (1981) Antigen on human monocytes identified by monoclonal antibodies. J Immunol 126:1435–1442

    Google Scholar 

  20. Majdic O, Liszka K, Lutz D, Knapp W (1981) Myeloid differentiation antigen defined by a monoclonal antibody. Blood 58:1127–1133

    Google Scholar 

  21. Vainchenker W, Deschamps JF, Bastin JM, Guichard J, Titeux M, Breton Gorius J, McMichael A (1982) Two monoclonal antiplatelet antibodies as markers of human megakaryocyte maturation. Immunofluorescent staining and platelet peroxidase detection in megakaryocyte colonies and in vivo cells from normal and leukemic patients. Blood 59:514–521

    Google Scholar 

  22. Swart K, Hagemeijer A, Lowënberg B (1982) Acute myeloid leukemia colony growth: differences of colony forming cells in PHA-supplemented and standard leukocyte feeder cultures. Blood 59:816–821

    Google Scholar 

  23. Howell AL, Stukel TA, Bloomfield CD, Ball ED (1992) Predictive value of flow cytometric analyses of blast cells in assessing the phenotype of the leukemia colony-forming cell (L-CFC) population in acute myloid leukemia. Bone Marrow Transplant 10:261–266

    Google Scholar 

  24. Löwenberg B, Bauman JGJ (1985) Further results in understanding the subpopulation structure of AML: clonogenic cells and their progeny identified by differentiation markers. Blood 66:1225–1232

    Google Scholar 

  25. Griffin JD, Larcom P, Schlossman SF (1983) Use of surface markers to identify a subset of acute myelomonocytic leukemia cells with progenitor cell properties. Blood 62:1300–1303

    Google Scholar 

  26. Fialkow PJ, Tinger JW, Adamson JW, Vaidya K, Dow LW, Ochs J, Moohr JW (1981) Acute nonlymphocytic leukemia: Heterogeneity of stem cell origin. Blood 57:1068–1073

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

del Cañizo, M.C., Almeida, J., Miguel, J.F.S. et al. The phenotype of L-CFU and its correlation with the immunological characteristics of the blast cell population in AML. Ann Hematol 68, 233–236 (1994). https://doi.org/10.1007/BF01737422

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01737422

Key words

Navigation